<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The work is based on an analysis of 95 clinical observations of patients with primary and metastatic <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e> who were in the surgical department of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of the liver and pancreas of the State Research Institute named by N.N </plain></SENT>
<SENT sid="1" pm="."><plain>Blokhin of RAMS from 1990 to 2011 </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent two or more liver resections </plain></SENT>
<SENT sid="3" pm="."><plain>Of <z:hpo ids='HP_0000001'>all</z:hpo> 95 patients included in this study, 64 underwent repeated interventions over a liver colorectal <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>10 patients had the operations, which were performed for primary <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo> of the liver </plain></SENT>
<SENT sid="5" pm="."><plain>In 21 patients re-resection were performed for metastatic lesions of other <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> nosology </plain></SENT>
<SENT sid="6" pm="."><plain>Postoperative mortality in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> lesions of the liver in patients who underwent repeat resection was 1.05%, postoperative complications occurred in 38.9% of patients </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> who underwent repeat resection of various sizes, five-year survival rate was 53.3Â±8.8% </plain></SENT>
<SENT sid="8" pm="."><plain>Median 35.9 months </plain></SENT>
<SENT sid="9" pm="."><plain>The low level of mortality and acceptable level of postoperative complications in patients re-operated <z:e sem="disease" ids="C0023903" disease_type="Neoplastic Process" abbrv="">liver tumor</z:e>, as well as high rates of long survival confirm the thesis about the need for such interventions as part of combined treatment of this difficult group of patients </plain></SENT>
</text></document>